Contracts › 75N95025P00265
75N95025P00265: Indi Alfatag Cell Lines for the Ipsc Neurodegenetive Disease Initiative (INDI) Project
Awarded to Jackson Laboratory by National Institutes of Health (NIH).
$1.5Mobligated
$1.5Mpotential value
31 July 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95025P00265 |
|---|---|
| Awardee | Jackson Laboratory |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | ME |
| Offers received | 1 |
| Period of performance | 01 August 2025 to 31 July 2026 |
| Potential end | 31 July 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record